DOCS — Dr Martens Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMid CapContrarian

Annual income statement for Dr Martens, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	454	672	773	908	1,000
Cost of Revenue
Gross Profit	261	402	471	579	618
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	386	530	661	679	824
Operating Profit	68	143	113	229	176
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	28.9	101	70.9	214	159
Provision for Income Taxes
Net Income After Taxes	17.2	74.8	35.7	181	129
Net Income Before Extraordinary Items
Net Income	17.2	74.8	35.7	181	129
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	17.2	74.8	35.7	181	129
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.021	0.084	0.077	0.181	0.132
Dividends per Share